MassBio
  • Member Directory
  • Events
  • Purchasing & Rewards
  • Discover
  • Why Massachusetts
  • Careers
  • News
  • About
  • Become a Member Company
  • Log In / Create Account
  • @MassBio
  • LinkedIn

Introducing the MassBioHub

MassBio's Conference & Business Center

Book your meeting or event today with the MassBioHub, MassBio's new conference & business center in Kendall Square, exclusively for members to rent at 25-40% below-market rates. 

Tour the Hub & See Pricing Info!

Discover
  • Knowledge Base
  • MassCONNECT
  • Policy & Advocacy
  • Digital Health
  • Diversity
  • Value of Health
  • Academic Outreach & Engagement
  • Funding Opportunities
  • Post Knowledge

Knowledge Base

Articles 1 - 10 of 15 Prev Page 1 2 Next Page
Perspectives on Gene Therapy: Defining and Demonstrating Value to Payers Precision Xtract November 26, 2019
  • Advocacy,
  • CRISPR & CAR-T,
  • Drug Cost,
  • Gene editing,
  • Innovation

Explore the current landscape of gene therapy to highlight the challenges payers, health systems, and manufacturers face in bringing these innovative medicines to the patients who need them most. Read More

Member Only
Delivering on the Promise of Cell Therapy: Challenges and Trends Precision Xtract November 20, 2019
  • Access,
  • Advocacy,
  • CRISPR & CAR-T,
  • Drug Cost,
  • Gene editing,
  • Innovation,
  • Value

Explore the current landscape of cell therapy (e.g. CAR-T), highlighting challenges and opportunities sponsors face as they endeavor to translate these treatments from the bench to the bedside. Read More

Member Only
From Data Chaos to Order & Insight: Creating a Connected Data Ecosystem to Drive Drug Development Precision Xtract November 14, 2019
  • Biomanufacturing,
  • Drug Cost

Explores the challenges of organizing these complex data sets and makes recommendations for creating a data ecosystem that can generate actionable insights. Read More

Member Only
What Do Value Assessments Miss? Precision Xtract November 14, 2019
  • Access,
  • Drug Cost,
  • Economic Impact,
  • Innovation,
  • Policy,
  • Value

Understand key drivers of the value conversation and how the definition of value goes beyond quality & cost of care to include other dimensions that should be factored into developing value frameworks Read More

Member Only
Hogan Lovells: Life Sciences and Health Care Horizons 2019 Hogan Lovells March 22, 2019
  • Access,
  • Alerts,
  • CRISPR & CAR-T,
  • Deals,
  • Drug Cost,
  • FDA,
  • Funding,
  • Gene editing,
  • Innovation,
  • Patent Reform,
  • Policy,
  • Startups

In the 2019 edition of our Life Sciences and Health Care Horizons publication, our global team identifies a number of current and evolving trends that are shaping the future of the industry. Read More

Member Only
Pricing for Survival: As demand for pharmaceutical cost containment intensifies, novel drug-pricing approaches are critical KPMG LLP April 19, 2018 in White Papers,
  • Drug Cost,
  • Value

In this piece, we explore the practical approaches to pricing for value that pharma manufacturers can leverage today. Read More

Member Only
Life Sciences and Health Care Horizons 2018 Hogan Lovells March 28, 2018 in White Papers,
  • Alerts,
  • CRISPR & CAR-T,
  • Deals,
  • Drug Cost,
  • FDA,
  • Federal Issues,
  • Funding,
  • Gene editing,
  • Innovation,
  • Patent Reform,
  • Policy,
  • Startups

Our global Life Sciences and Health Care team reports on current and evolving trends that are shaping the future of the industry. Read More

Member Only
Business success in the life sciences: an investment banker’s perspective June 28, 2017 in White Papers,
  • Access,
  • Deals,
  • Drug Cost,
  • Economic Impact,
  • Innovation,
  • Workforce Development

As we are passionate about bringing paradigm-shifting technologies to patients, we were excited by the opportunity to facilitate transatlantic collaborations between Boston’s biotech hub and the life Read More

Member Only
Platforms versus products in the life sciences sector June 23, 2017
  • Access,
  • Deals,
  • Drug Cost,
  • Economic Impact,
  • FDA,
  • Funding,
  • Innovation

In an expert view piece, Dr Oded Ben-Joseph and Dr Shawn Manning, from investment bank Outcome Capital, advise on how life sciences companies can curtail risk by allocating time and money in a capital Read More

Member Only
Automating Excursion Management for Real-Time Resolution in the Pharmaceutical Manufacturing Process New England Controls November 29, 2016 in White Papers,
  • Biomanufacturing,
  • Drug Cost,
  • Economic Impact,
  • Innovation,
  • Value

This paper summarizes traditional methods of tracking excursions and presents an alternative automated method to track and resolve excursions in a more timely fashion that will reduce the time and costs associated with... Read More

Member Only
Articles 1 - 10 of 15 Prev Page 1 2 Next Page

Category

  • All
  • White Papers
  • Advisories
  • Research Papers
  • Checklists
  • Training Sessions
  • Presentation & Video Library
Popular Tags
  • Innovation57,
  • Value44,
  • Policy36,
  • Workforce Development26,
  • Advocacy22,
  • Startups22,
  • Alerts21,
  • Economic Impact21,
  • FDA21,
  • Federal Issues18,
  • Home
  • Legal
  • Contact
  • Get Email Updates
  • @MassBio
  • LinkedIn
  • Facebook
  • YouTube
Massachusetts Biotechnology Council 300 Technology Square, 8th Floor
Cambridge, MA 02139
617.674.5100

© 2019 All Rights reserved Powered by Getfused